Abstract
The role of point-of-care ultrasound (POCUS) in patient management has been established in recent years as an important tool. It is increasingly used by multiple medical disciplines in numerous clinical settings, for different applications and diagnostic purposes and in the guidance of procedures. The introduction of small-sized and inexpensive hand-held ultrasound devices (HUDs) has addressed some of the POCUS-related challenges and has thus extended POCUS’ applicability. HUD utilization is even more relevant in the COVID-19 setting given the operators’ infection risk, excessive workload concerns and general equipment contamination. This review focuses on the available technology, usefulness, feasibility and clinical applications of HUD for echocardiogram assessment in patients with COVID-19.
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference47 articles.
1. Spectrum of cardiac manifestations in COVID-19: A systematic echocardiographic study;Szekely;Circulation,2020
2. A review of cardiac manifestations and predictors of outcome in patients with COVID-19;Mishra;Heart Lung,2020
3. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study;Zhou;Lancet,2020
4. Bedside focused cardiac ultrasound in COVID-19 from the Wuhan epicenter: The role of cardiac point-of-care ultrasound, limited transthoracic echocardiography, and critical care echocardiography;Zhang;J. Am. Soc. Echocardiogr.,2020
5. Task Force for the management of COVID-19 of the European Society of Cardiology (2022). European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: Part 1—epidemiology, pathophysiology, and diagnosis. Eur. Heart J., 43, 1033–1058.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献